mRNA for four-transmembrane L6 family member 5 (TM4SF5), a homolog of tumor antigen L6, was previously shown to be highly expressed in diverse tumors. We recently found that human hepatocarcinoma tissues also overexpressed TM4SF5 protein, in comparison to normal liver tissues. We also found that tiarellic acid (TA) caused cell detachment-related apoptosis in cells expressing endogenous or stably-overexpressing TM4SF5. When cells expressing TM4SF5 were treated with TA, we observed reduced phosphorylation of focal adhesion kinase, paxillin, and p130Cas, but not c-Src. TA treatment also caused focal adhesion loss and reduced cell adhesion, and increased the numbers of floating cells and apoptotic cells. These effects were blocked by overexpression of focal adhesion molecules, suggesting that treatment with TA mediates anoikis of TM4SF5-expressing cells. However, TM4SF5-null cells were not affected by TA, indicating that these effects occur specifically in TM4SF5-positive cells. TA administration reduced tumor formation in nude mice injected with TM4SF5-expressing cells, presumably through increased apoptosis in TM4SF5-positive tumors. These observations indicate that TM4SF5-positive tumorigenesis can be inhibited by TA via induction of cell detachment-related apoptosis, and suggest that TA may be developed as a putative therapeutic reagent against TM4SF5-positive tumorigenesis.
Introduction
Integrin-mediated cell adhesion triggers diverse intracellular signal transductions that regulate the activities and localizations of diverse signaling molecules, and consequently cell behaviors [1] [2] [3] . When integrins interact extracellularly to extracellular matrix (ECM) at focal adhesions, intracellular cytoplasmic tails of integrin subunits recruit diverse focal adhesion molecules including FAK, paxillin, p130Cas, c-Src, and etc [4] . Since the integrins at the focal adhesions are linked to actin filaments through protein complexes at their cytoplasmic tails [5, 6] , inefficient assembly and activation of focal adhesion molecules and/or abnormal reorganization of actin filaments can cause cells to be round-shaped with concomitant loss of focal adhesions, leading to consequent detachment of cells from and disruption of the epithelial integrity on basement membrane [7] .
However, cancer cells due to multiple mutations and genomic instabilities may be allowed to disseminate from a primary tumor by abnormal alteration of cell-ECM interactions and cell-cell contacts [8] . In the steps of disruption of basement membrane and migration/invasion through stromal region for cancer metastasis, integrin-mediated adhesion of cancer cells to ECM may critically affect the metastatic potential of cells [9] [10] [11] . Among disseminated cancer cells, only cells survived anoikis may travel to distant sites via blood and lymphoid vessels, and eventually attach to a site and proliferate as metastatic tumors [12] . Therefore, it would be useful to find reagent(s) to cause apoptosis or anoikis of tumorigenic cells without any effects on normal cells, when antitumorigenic or metastatic reagents are being screened.
TM4SF5 (also known as L6H) is a homolog of tumor-associated antigen L6 (TM4SF1) and forms a four-transmembrane L6 superfamily with L6, IL-TMP, and L6D [13] . TM4SF5 is highly expressed in diverse tumor types [14, 15] . Tetraspanins (also known as TM4SF or tetraspans) are a group of hydrophobic proteins of 25-50 kDa with four transmembrane domains, two extracellular loops, and two short cytoplasmic tails [16] . The extracellular loop 2 (EC2) of genuine tetraspanins has a variable region that mediates specific protein-protein interactions and a conserved region that mediates homodimerization [16] . The EC2 loop of TM4SF5, a member of a four-transmembrane L6 superfamily, however, is relatively divergent and has 2 cysteine residues, whereas the EC2 of genuine tetraspanins has a variable region and conserved 4 cysteines for disulfide bonding while correct folding [13] . Four transmembrane domains of tetraspanins are suggested to be responsible for intra-and inter-molecular interactions during biosynthesis and organizing the 'tetraspanin-web' on cell surface [16] . Tetraspanins form complexes with integrins to collaboratively perform their roles in cell adhesion, proliferation, and motility [17, 18] . It was previously shown that KAI1/CD82 expression in Du145 prostate cells down-regulated p130Cas leading to suppression of cell motility, and overexpression of p130Cas in the cells reversed the inhibited motility [19] . Meanwhile, we recently found that TM4SF5 overexpression in hepatocytes caused actin reorganization through regulation of FAK and RhoA activity, leading to losses of cell-cell adhesion and contact inhibition [20] . We have also observed that ectopic TM4SF5 in fibroblasts was shown to interact with integrin α2 to regulate focal adhesion turnover and actin reorganization [21] . Therefore, it is likely that TM4SF5 may cross-talk with the integrins to regulate cellular functions.
While trying to identify reagents to regulate TM4SF5-mediated cell proliferation, we found that tiarellic acid [TA, [22] ] could cause cell detachment-related death in a TM4SF5 expression-dependent manner. TA treatment decreased phosphorylation of focal adhesion molecule and cell adhesion, enhanced apoptosis of TM4SF5-expressing (but not -null) cells, and interfered with TM4SF5-mediated tumor formation in nude mice. Altogether, these observations suggest that TA may be a putative anti-tumorigenic reagent specifically against TM4SF5-positive tumors.
Materials and methods

Cells
Pooled stable clones (control SNU449Cp and TM4SF5-expressing SNU449Tp cell clones) and single cell-driven stable clones (TM4SF5-expressing SNU449T16) were prepared by infecting SNU449 hepatocytes (Korean Cell Bank, Korea) with retrovirus for empty pLNCX or pLNCX with TM4SF5 [20] . Stable and TM4SF5-null parental cells were maintained in RPMI-1640/10% FBS/0.25 μg/ml gentamycin (Calbiochem, San Diego, CA) with or without 200 μg/ml G418 (A.G. Scientific Inc., San Diego, CA), respectively, at 37°C and 5% CO 2 . Other cell lines with or without endogenous TM4SF5 (Korean Cell Bank) were maintained in either DMEM-H or RPMI-1640 media with 10% FBS (JBI Inc., Daegu, Korea).
Preparation of tiarellic acid (TA)
Whole plants of Tiarella polyphylla collected from Ullung island (Kyungsang-Bukdo, Korea) were extracted with MeOH, concentrated, suspended in water, partitioned successfully with EtOAc prior to column chromatography on silica gel eluting with hexane followed by hexane-EtOAc mixtures of increasing polarity and finally with CHCl 3 -MeOH (1:1) mixture, as previously explained [23] . HPLC (MeOH 58% + 0.2% TFA 42%) of TA (0.1 μg/μl, 3,23-dihydroxy-20(29)-lupen-27-oic acid, [22] ) was performed using Finnigan Surveyor HPLC system with column of Perfectsil Target ODS-3.
Cell lysate preparation and Western blots
Whole cell lysates from cells under diverse experimental conditions were prepared, as described previously [21] . In cases, cells were electroporated (at 950 μF and 250 V) with control GFP, wildtype FAK, paxillin, or p130Cas cDNA plasmid. One day after electroporation, cells were treated with TA (20 μM) for the indicated periods. Cells cultured normally or treated with TA at different concentrations for the indicated periods were harvested using RIPA buffer [21] . Control or tumor tissues from nude mice were frozen immediately after surgery using liquid N 2 . Tissues was homogenized in the liquid N 2 and extracted using 0.1% SDS containing RIPA buffer, prior to spin (13000 ×g, 30 min) at 4°C. 
Anti-TM4SF5
Rabbit polyclonal antibody was produced against amino acid residues from 120 to 132 of TM4SF5 (NM-003963) conjugated with keyhole limpet hemocyanin (KLH, A & Pep Inc., Yeongi-Gun, Korea). The sera were further purified by affinity chromatography using protein A/G-sepharose (Invitrogen).
Immunofluorescence microscopy
Cells were treated with DMSO or 20 μM TA for 24 h before being replated on fibronectin (10 μg/ml)-precoated coverslips for an additional 2 h incubation in the presence of DMSO or 20 μM TA. Fluorescent staining was performed, as described previously, for analysis by fluorescent microscopy (BX51, Olympus, Japan) [21] . width perpendicular to a. Intraperitoneal (IP) injection of TA (at 3 or 30 mg/kg body weight in 5% DMSO) to mice with TM4SF5-mediated tumors (~200 mm 3 of calculated tumor volume) was performed every other day for the indicated periods.
Mouse and tumor xenografts
Human liver tissue sample
Normal and tumor liver tissues were obtained from patients in the Kyungpook National University Hospital (Daegu, Korea) from March to April, 2007 with informed consent and IRB approval. Clinical and biological information was available for the tissue samples.
Tumor histology
Tumor tissues were removed about 6 weeks after injecting SNU449T16 cells or after TA IP injection for one month, fixed with formalin, and embedded in paraffin. Serial sections (6 μm thick) cut from each paraffin block were stained with anti-active caspase-3, prior to visualization by fluorescent microscopy (BX51, Olympus, Japan). Fig. 3 . TA causes inactivation of and complex disassembly among focal adhesion molecules in a dose-and time-dependent manner. (A to E) Cells were seeded to 60 mm culture dishes at about 40% density. One day after, cells were treated with DMSO or TA at diverse concentrations for the indicated periods. After incubation, lysates were prepared and used in standard Western blots for the indicated molecules. (D) An equal amount of proteins for each condition was immunoprecipitated with anti-p130Cas, before immunoblots with anti-phospho-Tyr to reveal p130Cas phosphorylation, or anti-FAK or -paxillin to determine complex formation among the molecules. Data shown represent three independent experiments.
Viability assay
Cells were seeded into 24 well culture plates at 1 × 10 5 cells/well. One day later, cells in triplicate were treated with TA at different concentrations for the indicated periods. After incubation, viable cells after trypan blue staining or total floating cells were counted.
Immunoprecipitation
Cell lysates were immunoprecipitated with p130Cas, integrin α5, or FAK antibody. The p130Cas immunoprecipitates were immunoblotted with anti-phospho-Tyr, FAK, or paxillin, whereas the FAK or integrin α5 immunoprecipitates were immunoblotted for integrin α5 or pY 397 FAK, respectively, as explained previously [24] .
Cell adhesion assay
Cells treated with DMSO or 20 μM TA for 24 h were trypsinized and suspended in RPMI-1640 containing 1% BSA. The cells were then processed for assay of adhesion on fibronectin for 1 h, as explained previously [25] .
DNA content assay
The DNA content analysis via propidium iodide staining was performed for cells with or without TA treatment, or for cells transfected with GFP, FAK, paxillin, or p130Cas wildtype with or without TA treatment (20 μM for 24 h), as previously explained [26] .
Statistical analysis
The Student's t-test was performed for comparison of mean values to see if the difference is significant. p values ≤0.05 were considered significant.
Results
TA treatment results in cell detachment-related death of TM4SF5-expressing cells
While investigating to see whether TM4SF5 might be associated with tumorigenesis, we found that TM4SF5 was significantly overexpressed in liver tumor tissue obtained from hepatocarcinoma patients, compared to normal liver tissue (Fig. 1A) . To identify reagents that have an effect on cells expressing TM4SF5, we screened diverse natural productdriven chemicals to observe selective cytotoxic effects against TM4SF5-expressing cells. We used TM4SF5-negative parental SNU449 and control stable SNU449Cp hepatocytes and TM4SF5-positive SNU449Tp and SNU449T16 stable cells (Fig. 1B, upper) to examine cytotoxic sensitivity to a variety of lupane-derived triterpenoid plant compounds. Among the compounds we tested, tiarellic acid (TA, Fig. 1C ) was found to inhibit growth of TM4SF5-expressing cells (Fig. 1D) , although TA treatment did not change TM4SF5 expression levels (Fig. 1B, lower) . TM4SF5-expressing SNU449Tp cells treated with TA showed cell death accompanied by rounded cell morphology (data not shown), whereas TM4SF5-null SNU449Cp cells were not affected by TA treatment. Treatment with 20 μM TA even for 1 day decreased the number of TM4SF5-expressing cells (Fig. 1D ). These observations indicate that TA might target other molecules(s) than TM4SF5 itself in the initiation of cell death. When we analyzed trypan blue stain-positive and floating cells after DMSO or TA treatment, we found that TA treatment increased the number of floating SNU449Tp cells, but not of control SNU449Cp cells (Fig. 1E) . TA treatment of SNU449T16 cells also resulted in Akt inactivation, Bcl-2 reduction, Bax induction, and caspase-3 activation, whereas no effects were seen in control SNU449Cp cells (Fig. 1F) . In addition, analysis of cellular DNA content after treatment with 20 μM TA for 24 h resulted in significant sub-G1 populations of SNU449Tp and T16, but not of control SNU449Cp cells (Fig. 1G) . The TA-mediated apoptosis rate was less than the overall loss in viability (Fig. 1D) , presumably due to different sensitivities of experimental methods and/or technical difficulties to collect all apoptotic bodies during sample preparation for FACS analysis. Therefore, these observations suggest that TA causes cell detachment-related death of TM4SF5-expressing cells.
We next evaluated whether TA treatment of cells overexpressing TM4SF5 was valid for cells that endogenously express TM4SF5. We examined the effects of TA treatment at 5 or 20 μM on cell growth and survival using diverse cell lines with or without endogenous TM4SF5 (Fig. 2A) . Growth of TM4SF5-null cells (including Hek293 and COS7 fibroblast, MDA-MB453 breast, SNU638 and SNU668 stomach, and SNU398 liver epithelial cells) was not affected by TA treatment; although Hek293 cells showed a slight retard of growth rate after TA treatment, they still increased in cell number (Fig. 2B left and data  not shown) . However, cells with endogenous TM4SF5 expression Fig. 4 (continued) . (including SNU368, HepG2, and Huh7 hepatocytes) showed growth suppression after TA treatment, leading to the eventual decrease in cell number (i.e., cell death) over time (Fig. 2B, right) .
TA-mediated inhibition of focal adhesion molecule activation and focal adhesion formation
To examine the molecular basis for TA-mediated cell detachment and death, we analyzed signaling molecules known to participate in focal adhesion upon integrin-mediated cell adhesion. SNU449 stable cell lines were treated with TA in a dose-and time-dependent manner. SNU449Cp or SNU449T16 cells were treated with varying TA concentrations for 24 h prior to immunoblot analysis. SNU449T16 cells treated with 20 μM TA showed reduced FAK and paxillin phosphorylation and p130Cas protein levels, whereas SNU449Cp cells were not affected (Fig. 3A) . TA treatment decreased FAK and paxillin phosphorylation and p130Cas protein levels in a time-dependent manner in SNU449T16, but not in SNU440Cp cells (Fig. 3B) . The TM4SF5-dependent inhibitory effects of TA on focal adhesion molecule phosphorylation and activity were observed in both SNU449Tp and T16 cell lines (Fig. 3C ). In addition, TA treatment decreased p130Cas phosphorylation and the physical association among FAK, p130Cas, and paxillin (Fig. 3D ). These observations indicate that TA treatment affected phosphorylation and complex formation of focal adhesion molecules only in TM4SF5-expressing cells. In addition, TA-mediated effects on focal adhesion molecule phosphorylation were examined in cells that express endogenous TM4SF5 and in null cell lines. The inhibitory effects of TA treatment were observed also in cells endogenously expressing, but not lacking, TM4SF5 (Fig. 3E) . Since TA suppressed focal adhesion molecule phosphorylation and complex formation, focal adhesion formation would likely be affected by TA treatment. We thus analyzed focal adhesion formation in TA-treated and -untreated cells by performing immunostaining for Tyr397-phosphorylated FAK (pY 397 FAK) or Tyr118-phosphorylated paxillin (pY 118 paxillin). Although TA treatment did not affect focal adhesion formation in TM4SF5-null cells, focal adhesions in TM4SF5-expressing cells were lost after TA treatment (Fig. 4A) . TA-mediated loss of focal adhesions appeared to involve a dissociation between integrin α5 and pY 397 FAK in TM4SF5-expressing cells (Fig. 4B ), being consistent with integrinmediated recruitment of focal adhesion molecules such as pY 397 FAK [21] . Furthermore, since focal adhesions are linked to each other via stress fibers [27] , we also stained actin in TA-treated and -untreated cells. Cells expressing TM4SF5 showed abnormal actin organization with insignificant stress fibers after TA treatment, whereas TM4SF5-null cells did not (Fig. 4C) . The loss of focal adhesions and stress fiber formation in TA-treated, TM4SF5-expressing cells could contribute to the observed cell rounding after TA treatment (data not shown).
Since TA treatment caused inactivation and disassembly of focal adhesion molecules, possibly contributing to a rounded morphology, and resulting in detachment-related apoptosis of TM4SF5-expressing cells, we next wondered whether TA treatment affected cellular adhesion. Cells treated with 20 μM TA for 24 h were collected and reseeded on fibronectin-precoated dishes for 1 h before determination of the degree of adhesion. Adhesion of TM4SF5-null SNU449 and SNU449Cp cells was not affected by TA treatment, whereas TM4SF5-expressing SNU449Tp and T16 cells pretreated with TA showed significantly reduced adhesions, compared to the control vehicletreated cells (Fig. 4D) . This observation appeared to be consistent with the observed TA-mediated detachment and death of TM4SF5-positive cells in Fig. 1. 
Overexpression of focal adhesion molecules blocked the TA-mediated effects
We next evaluated whether overexpression of FAK, paxillin, or p130Cas would block the effects of TA treatment, assuming that their expression to higher levels would result in more focal adhesion formation and activation. To explore this, we introduced each cDNA into SNU449T16 cells via electroporation. Due to transient overexpression of FAK, paxillin, or p130Cas, TA treatment was performed 1 day after electroporation. TA treatment of SNU449T16 cells introduced with control plasmid (for GFP) showed time-dependent inactivation of focal adhesion molecules and activation of caspase-3, supporting our hypothesis of TA-mediated apoptosis. However, SNU449T16 cells introduced with wildtype FAK, paxillin, or p130Cas resulted in certain degrees of blocking TA-mediated effects (Fig. 5A) . Furthermore, overexpression of the focal adhesion molecules also blocked TA-mediated increases in the sub-G1 population (Fig. 5B) . Therefore, the TA-mediated effects on TM4SF5-expressing cells could be overcome to a certain degree by overexpression of focal adhesion molecules.
TA interfered with TM4SF5-mediated tumor formation in nude mice
We next evaluated whether TM4SF5 mediated tumor formation in nude mice and whether TA administration might interfere with tumorigenesis. Nude mice injected with TM4SF5-expressing SNU449T16 cells formed significant tumors, whereas injection with TM4SF5-null SNU449Cp cells did not form tumors (Fig. 6A) . When TA was given intraperitoneally every other day for 30 days to mice with established tumors (~200 mm 3 of calculated tumor volume), TM4SF5-mediated tumor formation was decreased. Administration of TA at 3 or 30 mg/kg body weight decreased the tumor volumes to 46.0% or 22.1%, respectively, while body weight increased normally, indicating no significant toxic side effects (Fig. 6A) . Although we did not determine whether TA caused any local side effects in the TAtreated mice such as blood pressure decrease and mucosal damage, an intraperitoneal administration of TA at 2 g/kg did not cause any abnormal behaviors or abnormalities in organ structures until sacrifice after 2 weeks (S-R Oh and H-K Lee, unpublished observation). Western blot analysis using control tissue around the spot injected with control SNU449Cp cells and tumor tissue of SNU449Tp-injected mice revealed that TM4SF5-mediated tumor tissue showed Akt activation and caspase-3 inactivation, indicating signaling activities for tumor formation (Fig. 6B, lanes 1 to 2) . However, TA administration decreased Akt activation, increased p15 INK4B or p16 INK4A cyclin-dependent kinase inhibitor (CKI) levels, and enhanced caspase-3 activation, indicating that TA caused growth inhibition and apoptosis in the TM4SF5-mediated tumors (Fig. 6B , lanes 2 to 4). Immunohistochemical staining for active caspase-3 was positive in TM4SF5-mediated tumor tissue obtained from mice that had been treated with TA, but not from mice treated with vehicle DMSO (Fig. 6C ). Since we observed that TM4SF5-positive cells were undergoing apoptosis after TA treatment, it may be likely that doses higher than 30 mg/kg may cause cytostatic effects leading to dormancy of TM4SF5-mediated tumors in mice. On the other hand, nude mice injected with TM4SF5-negative CT26 murine colon carcinoma cells followed by TA treatment (30 mg/kg body weight) did not result in decreased tumor formation (Fig. 6D) . Therefore, TA specifically interfered with TM4SF5-mediated tumor formation in nude mice, presumably by enhancing apoptosis. These results suggest that TA might be developed further as a potential therapeutic reagent for TM4SF5-positive tumors.
Discussion
This study provides evidence that TM4SF5-positive cell growth and tumor formation in nude mice can be negatively regulated by tiarellic acid (TA), a component purified from T. polyphylla [22] . TA treatment resulted in the cell detachment-related death of TM4SF5-expressing cells, but not null cells; TA inhibited activation of and complex formation between focal adhesion molecules, blocked formation of focal adhesions, decreased adhesion property, and increased death in cells ectopically and endogenously expressing TM4SF5. TM4SF5 mRNA is overexpressed in diverse tumor types [14, 15] and we show in this study that TM4SF5 protein is overexpressed in human hepatocarcinoma tissue. Therefore, the significance of TA-mediated apoptosis in TM4SF5-expressing cells can be important for therapeutic purposes against TM4SF5-positive cancers, although the precise target of TA during the TA-mediated detachment-related death of TM4SF5-expressing cells is unknown.
Other genuine tetraspanins form tetraspanin-web structures by interacting with integrins to collaboratively perform their functions in cell adhesion, proliferation, and motility [17, 18, 28] . We have previously reported that TM4SF5 regulates focal adhesion turnover and actin reorganization in fibroblasts, depending on the association with integrin α2 [21] . In addition, TM4SF5 in hepatocytes was shown to modulate cellular morphology via regulation of FAK and RhoA activities [20] . TM4SF5 may thus modulate architectural integrity and/or signaling activity of membrane proteins, including integrins and other membrane receptors. TA was previously shown to reduce MMP-1 expression and induce type 1-procollagen expression after ultraviolet irradiation of primary human skin fibroblasts [23] , although it is not known whether the primary skin fibroblasts express TM4SF5 or not. Therefore, TA appears to regulate the behaviors of TM4SF5-expressing cells by influencing cell adhesion-related molecules. TA treatment of Hek293 cells lacking TM4SF5 resulted in a slight growth retard, although they still were divided to positively increase cell numbers, whereas other TM4SF5-negative cell lines were not influenced (Fig. 2B) . Therefore, it cannot be ruled out that Hek293 cells may express a TM4SF5-related protein, such as L6 (TM4SF1), IL-TMP, and L6D, or that TA may also have alternative targets involved in Hek293 cell adhesion, which do not exist in SNU449 cells.
Lupane-derived triterpenoid compounds with a pentacyclic backbone like TA have been known for 20 years to have cytostatic activity [29] . Dehydrothyrsiferol, a triterpenoid, was recently shown to modulate integrin affinity without changing the expression of cell surface integrin expression, FAK, or Akt phosphorylation levels, leading to anoikis of human breast cancer cells [30] . TA is not soluble in water or culture media but in DMSO and would not generally affect cell adhesion property via its function as a detergent, since TA treatment caused detachment-related death only of TM4SF5-expressing cells, but not -null cells. Our observations with chemical derivatives of TA suggest that a structural specificity of TA exists to inhibit proliferation and survival of TM4SF5-positive cells, indicating that a COOH group at C 27 is important for the inhibitory effects on growth and survival of TM4SF5-positive cells (in preparation). On the other hand, tetraspanins or TM4SFs form massive complexes with integrins on the cell surface to function in cell adhesion [28] . Although attempts to coimmunoprecipitate TM4SF5 and integrin α5 in the absence of TA treatment of SNU449Tp or T16 cells failed, the connection between integrin and pY 397 FAK was disrupted by TA treatment. Therefore, TA may interfere with the cross-talk between TM4SF5 and integrins, at the level of effectors downstream of the receptors, which may be important for regulation of focal adhesion assembly and cell-ECM adhesion.
